Innovative Thinking
We’ve compiled these resources and articles that reflect our commitment to emerging technology and healthcare trends.
Beyond Compliance: Using Cleanroom Certification Reports to Strengthen Your Quality Program
Most sterile compounding organizations recognize cleanroom certification as a regulatory requirement.
One Year of The Compound Blog: 12 Lessons That Shaped Better Sterile Compounding
Over the past year, we've explored training, contamination control, environmental monitoring, hazardous drug safety, competency assessment, and operational excellence.
Should Compounders Sanitize Their Gloves During a Media-Fill Test?
Should compounders sanitize gloves during a media-fill test? Learn how realistic competency assessments support aseptic technique and USP <797> compliance.
USP <797>: Where Compliance Breaks Down—and How to Close the Gap
USP <797> provides a comprehensive framework for sterile compounding—but it does not function as an operational playbook. Most organizations are not struggling because they are unaware of the requirements. They struggle in the space between what the chapter says and what daily practice actually looks like.
USP <797> Contamination Control: Where Best Practices Make the Difference
USP <797> sets clear expectations for preventing contamination in sterile compounding—but compliance alone doesn’t guarantee control. True contamination control depends on how consistently best practices are applied in daily operations, especially in three high impact areas: garbing and hand hygiene, material transfer, and cleanroom behavior.
USP <797> Table 2 vs. Table 3: What’s the Difference — and Why It Matters for Ongoing Competency
Viable air and surface sampling are often treated as a second thought. Results are reviewed, levels are checked, and the program moves on until there’s exceeded an action level. But USP <797> never intended viable monitoring to be a passive exercise.
Viable Air and Surface Sampling Under USP <797>: What the Data Is Meant to Tell You
/
1 Comment
Viable air and surface sampling are often treated as a second thought. Results are reviewed, levels are checked, and the program moves on until there’s exceeded an action level. But USP <797> never intended viable monitoring to be a passive exercise.